Page last updated: 2024-12-06
indoxyl phosphate
Description
Indoxyl phosphate (IP) is a compound formed in the liver during the metabolism of tryptophan. It is a potential biomarker for kidney function, as its levels in the blood increase when the kidneys are not functioning properly. IP is synthesized from indoxyl sulfate, which is produced by the liver during the metabolism of tryptophan. IP can accumulate in the blood and tissues of patients with chronic kidney disease (CKD), and it has been linked to several complications of CKD, including cardiovascular disease, anemia, and bone disease. The accumulation of IP is thought to contribute to these complications by inducing oxidative stress and inflammation. IP is also being studied as a potential therapeutic target for CKD. The enzyme indoxyl sulfatase (IS) is responsible for the breakdown of IP. Studies are being conducted to develop drugs that can inhibit IS, thereby reducing the levels of IP in the blood and potentially improving the outcomes of patients with CKD.'
indoxyl phosphate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 26292 |
SCHEMBL ID | 540158 |
MeSH ID | M0105263 |
Synonyms (10)
Synonym |
indoxylphosphate |
1h-indol-3-yl dihydrogen phosphate |
indoxyl phosphate |
13822-19-0 |
1h-indol-3-ol, dihydrogen phosphate (ester) |
SCHEMBL540158 |
DTXSID60160538 |
disodium,1h-indol-3-yl phosphate |
FD10325 |
PD150848 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.41 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.36 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |